EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Genetic ALS —Progressive Sleep Defects Precede the Onset of Clinical Disease

Christina Lang iD, Simon J Guillot iD, Antje Knehr, Patrick Weydt iD, Johannes Dorst iD, Hayrettin Tumani iD, Albert C Ludolph, Luc Dupuis iD, Matei Bolborea iD

European Journal of Neurology · 2026

DOI: 10.1111/ene.70755 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Neurology, 2026. Verfasst von Christina Lang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Sleep Wake Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche, Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone, French Muscular Dystrophy Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The onset of amyotrophic lateral sclerosis (ALS) is preceded by non‐motor signs detectable many years before motor symptom onset. We recently showed that early ALS patients and presymptomatic carriers of ALS‐associated gene mutations display altered sleep macroarchitecture, characterised by increased wakefulness and decreased non‐REM sleep, together with altered microarchitecture, particularly reduced slow oscillations and sleep spindles. Here we aimed at determining whether sleep alterations are progressive in premanifest carriers of ALS‐associated gene mutations.

Methods

This longitudinal observational cohort study included presymptomatic first‐degree relatives of ALS patients carrying pathogenic gene mutations ( n = 18) and noncarrier family members ( n = 3). Sleep macroarchitecture and sleep microarchitecture were assessed using standardised polysomnography and electroencephalographic analyses at baseline and in a follow‐up examination after 2.3 ± 1.5 years.

Results

In all carriers, sleep alterations were more severe at follow‐up compared to the initial examination, for both macro‐ and microarchitecture. The progression of sleep alterations was seemingly independent of proximity to motor onset, whether evaluated by increased neurofilament levels or phenoconversion during the study period.

Conclusions

Sleep macro‐ and microarchitectural abnormalities progressively worsen during the premanifest phase of ALS. These findings suggest that polysomnography‐derived sleep measures and their neurochemical correlates may serve as sensitive, noninvasive surrogate biomarkers of disease progression in clinically silent ALS. This could support disease prevention, for example, by the antisense oligonucleotide tofersen in patients carrying SOD1 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisSleep Wake DisordersHumansFemaleMalePolysomnographyDisease ProgressionMiddle AgedElectroencephalographyLongitudinal StudiesAdultSuperoxide Dismutase-1MutationC9orf72 ProteinAgedCohort Studies

Stichwörter der Autor:innen

C9orf72SOD1electroencephalographypolysomnography

Substanzen

Superoxide Dismutase-1C9orf72 ProteinC9orf72 protein, humanSOD1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, University Hospital of Ulm, Ulm, Germany.
  • Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.
  • University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP - CRBS, UMR-S 1329, Strasbourg, France.
  • Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
  • Institute of Applied Physiology, University of Ulm, Ulm, Germany.

ORCID-Profile: Christina Lang, Simon J Guillot, Patrick Weydt, Johannes Dorst, Hayrettin Tumani, Luc Dupuis, Matei Bolborea

Förderung

  • Agence Nationale de la Recherche
  • Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone
  • French Muscular Dystrophy Association
  • Target ALS

Zitieren

APA

Lang, C., Guillot, S. J., Knehr, A., Weydt, P., Dorst, J., Tumani, H., Ludolph, A. C., Dupuis, L., & Bolborea, M. (2026). Genetic ALS —Progressive Sleep Defects Precede the Onset of Clinical Disease. European Journal of Neurology. https://doi.org/10.1111/ene.70755

Vancouver

Lang C, Guillot SJ, Knehr A, Weydt P, Dorst J, Tumani H, et al. Genetic ALS —Progressive Sleep Defects Precede the Onset of Clinical Disease. European Journal of Neurology. 2026. doi:10.1111/ene.70755

BibTeX
@article{Lang2026,
  author = {Lang, Christina and Guillot, Simon J and Knehr, Antje and Weydt, Patrick and Dorst, Johannes and Tumani, Hayrettin and Ludolph, Albert C and Dupuis, Luc and Bolborea, Matei},
  title = {Genetic ALS —Progressive Sleep Defects Precede the Onset of Clinical Disease},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70755}
}
Kostenlos starten →